Capabilities by Region: Australia

Greenhill has considerable advisory experience in Australia. Our Managing Directors and professionals have advised clients on transactions involving many of the leading companies in the region and have access to a network of corporate relationships throughout Australia.

Greenhill established its presence in Australia in April 2010 with the acquisition of Caliburn, the leading independent investment bank in the region.

For more information on Greenhill’s advisory practice in Australia and our capabilities in the region, please contact Managing Director Roger Feletto or Richard Phillips.

Below we highlight a few of the recent transactions on which we have advised in this region:

Recent Transactions

11-Feb-25
$320 million (AUD value)
Australia flag
Target: 

Pacific Smiles Group

Australia flag
Acquiror: 
Genesis Capital

Advised Pacific Smiles Group Limited, one of Australia’s leading and fastest growing dental service organisations, on its response to multiple private equity proposals and ultimate sale to Genesis Capital by way of off-market takeover

14-Jan-25
Pending
$166.5 million (AUD value)
Australia flag
Target: 

Bullabulling Gold Project

Australia flag
Acquiror: 
Minerals 260

Advising Minerals 260 on its purchase of the Bullabulling Gold Project from Norton Gold Fields (a wholly-owned subsidiary of one of the world’s largest gold producers, Zijin Mining Group)

24-Jul-24
Undisclosed
Australia flag
Target: 

INX Software

United States flag
Acquiror: 
Accel-KKR

Advised Tanarra Capital, leading diversified alternative asset investment firm in Australia, on its sale of INX Software, leading end-to-end workforce management and EHS software provider for high-risk, complex and remote businesses, to Accel-KKR

02-Jul-24
$250 million
Australia flag
Target: 

Liontown Resources Limited

Korea flag
Acquiror: 
LG Energy Solution

Advised Liontown Resources on its strategic partnership and convertible note funding with LG Energy Solution

26-Jun-24
Pending
$630 million
Euro flag
Target: 

Haleon plc’s Nicotine Replacement Therapy Business (ex-US)

India flag
Acquiror: 
Dr. Reddy’s Laboratories

Advising Haleon plc on the sale of its global nicotine replacement therapy business (ex-US) to Dr. Reddy’s Laboratories

Pages

show all